The clinical trial results of India’s first CAR T-cell therapy, published in The Lancet, show that it worked for nearly 73 per cent of patients. These results come from the Phase I and II trials of ...

Copyright: © 2025 Published by Elsevier Ltd. As a clinician, educator, and emotion researcher, I have long believed that our efforts to optimise the wellbeing of ...

1,2 In The Lancet Haematology, Miguel R Abboud and colleagues report on the STAND trial, which expanded on the SUSTAIN trial to include paediatric patients, higher doses of crizanlizumab, and 65 sites ...